Vascular endothelial growth factor in serum indicates cardiovascular risk in urology patients

Scandinavian Journal of Urology and Nephrology

Volumn 40, Issue 2, 2006, Pages 144-148

  Hahn, Robert G ^a   Yin, Li ^b   Ekengren, Jan ^c   Sandfeldt, Lars ^d  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Nacka Hospital   (Sweden)

^d Sabbatsberg Hospital   (Sweden)

Author keywords

Cardiovascular disease; Cytokine; Lower urinary tract symptoms; Prostate

Indexed keywords

VASCULOTROPIN;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEATH; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; ORGAN GROWTH; PRIORITY JOURNAL; PROSTATE; PROTEIN DETERMINATION; RISK ASSESSMENT; SMOKING; STROKE; SURVIVAL; SYMPTOM; UPREGULATION; UROLOGY;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS; SWEDEN; UROLOGIC DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646271986     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590500368666     Document Type: Article

References (20)

1. Josko J, Gwózdz B, Jedrzejowska-Szypulka H, Hendryk S. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. Med Sci Monit 2000;6:1047-52.
2. Bates DO, Lodwick D, Williams B. Vascular endothelial growth factor and microvascular permeability. Microcirculation 1999;6:83-96.
3. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39.
4. Jackson MW, Bentel JM, Tilley WD. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J Urol 1997;157:2323-8.
5. Haggstrom S, Lissbrant IF, Bergh A, Damber JE. Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. J Urol 1999;151:1620-1.
6. Haggstrom S, Torring N, Moller K, Jensen E, Lund L, Nielsen JE, et al. Effects of finasteride on vascular endothelial growth factor. Scand J Urol Nephrol 2002;36:182-7.
7. Pareek G, Shevchuk M, Armenakas NA, Vasjovic L, Hochberg DA, Basilotte JB, et al. The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients. J Urol 2003;169:20-3.
8. Hahn RG, Farahmand BY, Hallin A, Hammar N, Persson PG. Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy. Urology 2000;55:236-40.
9. Sandfeldt L, Hahn RG. Cardiovascular risk factors correlate with prostate size in men with bladder outlet obstruction. BJU Int 2003;92:64-8.
10. Hammarsten J, Hogstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press 1999;8:29-36.
11. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000;342:626-33.
12. Sasaki Y, Kawamoto A, Iwano M, Kurioka H, Takase E, Kawata H, et al. Vascular endothelial growth factor mRNA synthesis by peripheral blood mononuclear cells in patients with acute myocardial infarction. Int J Cardiol 2001;81:51-60.
13. Soeki T, Tamura Y, Shinohara H, Tanaka H, Bando K, Fukuda N. Serial changes in serum VEGF and HGF in patients with acute myocardial infarction. Cardiology 2000;93:168-74.
14. Chung NAY, Lydakis C, Belgore F. Angiogenesis in myocardial infarction. An acute or chronic process? Eur Heart J 2002;23:1604-8.
15. Klein JP, Moeschberger ML. Survival analysis. New York: Springer; 1997.
16. Chung NA, Lydakis C, Belgore F, Li-Saw-Hee FL, Blann AD, Lip GYH. Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease. Heart 2003;89:1411-5.
17. Chin BSP, Blann AD, Gibbs CR, Chung NAY, Conway DG, Lip GYH. Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure. Eur J Clin Invest 2003;33:941-8.
18. Asselbergs FW, de Boer RA, Diercks GFH, Langeveld B, Tio RA, de Jong PE, et al. Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria? Int J Cardiol 2004;93:211-5.
19. Thickett DR, Armstrong L, Christie SJ, Millar AB. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;164:1601-5.
20. DeVita F, Orditura M, Lieto E, Infusino S, Morgillo F. Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. Cancer 2004;100:270-8.